2B Scientific adds business manager to support growth

2B Scientific has appointed Nihad Robinson as business manager.

2B Scientific, a life science products distributor to the UK market, has appointed Nihad Robinson as business manager.

Robinson joins the Upper Heyford, Oxfordshire firm from Cambridge Biosciences where she was responsible for technical sales in the South UK region. She has a degree in microbiology and a PhD in molecular biology, as well as being fluent in Arabic and French.

"I am very proud to be joining 2BScientific and look forward to helping develop the business," she said.

2B Scientific has also expanded its worldwide supplier network by signing deals with Spring Bioscience and BioDynamics.

"We are excited about our new partnerships with US-based Spring Bioscience and Japan's BioDynamics (Funakoshi)," said James Bernard, md of 2B Scientific. "Both of these companies have established businesses and the expertise that will help position the products successfully in the market."

2B Scientific has extended its catalogue portfolio to include Spring Bioscience's cancer markers and tumour suppressors, plus BioDynamic's Hetero-Stagger PCR Cloning Kit, which enables efficient and fast cloning of PCR products without needing any enzymatic procedures.

The firm also offers products from Acris Antibodies (Germany); Cosmo Bio (Japan); Symansis (New Zealand); and ExBio (Czech Republic), among others.

You may also like

Manufacturing

Almac highlights SDS-PAGE approach for residual protein determination in new white paper

New white paper explores robust analytical method for residual protein detection in biocatalytic API manufacturing
Manufacturing

Reliable, high-performance pump for HPLC and UHPLC

Biotech Fluidics announce the ASI 540 – an affordable, standalone solvent delivery pump - design optimised for liquid chromatography applications
Manufacturing

BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech

The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Manufacturing

Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform

The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services collaborate to support ADC development and manufacturing

Piramal and Ajinomoto Bio-Pharma Services have entered a collaborative arrangement aimed at enhancing their customers’ ADC development and manufacturing programs
Manufacturing

Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market

Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Manufacturing

Japanese pharma companies shifting to earlier CDMO outsourcing as peptide complexity increases

Neuland Laboratories has reported a notable shift in Japanese pharmaceutical outsourcing patterns during the past 12-24 months, with companies engaging CDMOs earlier in the development cycle
Subscribe now